Is Abivax S.A. (AAVXF) a Buy, Sell, or Hold?
OTC : AAVXF
Abivax S.A.
$80.03 USD
-$58.97 (-42.42%)
- Volume
- 500
- Average Volume
- 32
- Market Capitalization
- $5.88B
- P/E Ratio
- -24.45
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $139.00
- Year Low
- $10.33
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.75
Company Overview
OTC
Marc de Garidel
Biotechnology
Healthcare
AAVXF
69
FR
USD
Liquidity Metrics
0.10
8.75
8.75
8.20
0.00
Sales & Valuation
-$
0.00
18.04
-53.46
-2.33
Profitability
-$4.83
-$335.98M
0.00%
0.00%
-165.19%
-57.52%
P/E Metrics
-24.45
0.40
0.40
Analyst Price Target & Rating
2/5
0 Analysts
%
Financial Health Scores
38.34
3/9
$488.04M
$584.12M
$129.09M
-$423.51M
Key Metrics (TTM)
$8.2B
0.00
-32.87
8.75
-165.19%
-45.51%
-4.09%
-1.87%
-12786 days
Company Executives
| Name | Title |
|---|---|
| Ida Hatoum | Chief People & Compliance Officer |
| Hema Keshava | Senior Vice President of Finance |
| Marc de Garidel | Chief Executive Officer & Director |
| Mary Mantock | Senior VP & Global Head of Regulatory Affairs |
| Patrick Malloy | Senior VP & Head of Investor Relations |
| Didier Blondel | EVice President, Chief Financial Officer & Board Secretary |
| Kevin Shan | Vice President & Global Head of Biometrics |
| Jerome Denis | Executive Vice President of Process Development & Manufacturing |
| Pierre Courteille | Chief Business Officer |
| Chris Rabbat | Vice President & Global Head of Medical Affairs |
Poll Results
No votes yet today — be the first to share your view!
About Abivax S.A. (OTC:AAVXF) Stock
Abivax S.A., a French biopharmaceutical firm, specializes in the discovery and enhancement of pharmaceutical treatments targeting inflammatory conditions, infectious illnesses, and various forms of cancer. The company's flagship compound, ABX464, is currently undergoing Phase IIb clinical evaluations for ulcerative colitis, Crohn's disease, and COVID-19. It is also being assessed in Phase IIa trials for rheumatoid arthritis, and has successfully concluded Phase IIa studies demonstrating viral remission in individuals with HIV. Additionally, Abivax is advancing ABX 196, an investigational immune-enhancing agent, through Phase 1/2 clinical trials for its potential application in treating hepatocellular carcinoma. Further research initiatives by the company explore therapies for Dengue fever, ... influenza, and respiratory syncytial virus. Abivax S.A. holds licensing agreements with prominent French research institutions, including the French National Centre for Scientific Research, the University of Montpellier, and the Institut Curie. Established in 2013, the company maintains its primary offices in Paris, France.
Frequently Asked Questions
-
What is the current Abivax S.A. (AAVXF) stock price?
-
Abivax S.A.(OTC:AAVXF) stock price is $80.03 in the last trading session. During the trading session, AAVXF stock reached the peak price of $139 while $10.325 was the lowest point it dropped to. The percentage change in AAVXF stock occurred in the recent session was --42.42% while the dollar amount for the price change in AAVXF stock was -$58.97.
-
AAVXF's industry and sector of operation?
-
The OTC listed AAVXF is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of AAVXF?
-
Ida Hatoum | Chief People & Compliance Officer
Hema Keshava | Senior Vice President of Finance
Marc de Garidel | Chief Executive Officer & Director
Mary Mantock | Senior VP & Global Head of Regulatory Affairs
Patrick Malloy | Senior VP & Head of Investor Relations -
How many employees does AAVXF have?
-
Number of AAVXF employees currently stands at 69. AAVXF operates from 7-11 Boulevard Haussmann, Paris, IF 75008, FR.
-
Link for AAVXF official website?
-
Official Website of AAVXF is: https://www.abivax.com
-
How do I contact AAVXF?
-
AAVXF could be contacted at phone #33 1 53 83 08 41 and can also be accessed through its website. AAVXF operates from 7-11 Boulevard Haussmann, Paris, IF 75008, FR.
-
How many shares of AAVXF are traded daily?
-
The average number of AAVXF shares traded daily for last 3 months was 32.
-
What is the market cap of AAVXF currently?
-
The market value of AAVXF currently stands at $5.88B with its latest stock price at $80.03